Interestingly, the pooled HR for OS was 1.47 (95% CI: 1.14–1.89) in SNP subgroup, which suggested that CTLA-4 +49AA genotype was an independent adverse indicator for cancer prognosis. The gene discussed is CTLA4; the disease is cancer.